| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 62135-481-42 | 62135-481 | HUMAN PRESCRIPTION DRUG | Cephalexin | Cephalexin | POWDER, FOR SUSPENSION | ORAL | 20220201 | N/A | ANDA | ANDA065336 | Chartwell RX, LLC | CEPHALEXIN | 250 mg/5mL | 100 mL in 1 BOTTLE (62135-481-42) |
| 62135-481-49 | 62135-481 | HUMAN PRESCRIPTION DRUG | Cephalexin | Cephalexin | POWDER, FOR SUSPENSION | ORAL | 20220201 | N/A | ANDA | ANDA065336 | Chartwell RX, LLC | CEPHALEXIN | 250 mg/5mL | 200 mL in 1 BOTTLE (62135-481-49) |
| 62135-480-42 | 62135-480 | HUMAN PRESCRIPTION DRUG | Cephalexin | Cephalexin | POWDER, FOR SUSPENSION | ORAL | 20220201 | N/A | ANDA | ANDA065336 | Chartwell RX, LLC | CEPHALEXIN | 125 mg/5mL | 100 mL in 1 BOTTLE (62135-480-42) |
| 62135-480-49 | 62135-480 | HUMAN PRESCRIPTION DRUG | Cephalexin | Cephalexin | POWDER, FOR SUSPENSION | ORAL | 20220201 | N/A | ANDA | ANDA065336 | Chartwell RX, LLC | CEPHALEXIN | 125 mg/5mL | 200 mL in 1 BOTTLE (62135-480-49) |